WW2COVID-19: Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19

Sponsor
Corporacion Parc Tauli (Other)
Overall Status
Recruiting
CT.gov ID
NCT04481477
Collaborator
(none)
450
1
4.6
98.5

Study Details

Study Description

Brief Summary

The aim of the study is to find out what care patients affected by anxiety, fear or loneliness have perceived and the perceived impact of this care. This knowledge will allow us to design measures aimed at improving nursing care of these aspects in the future.

Condition or Disease Intervention/Treatment Phase
  • Other: Nursing care to reduce anxiety, fear and loneliness

Detailed Description

This is a cross-sectional descriptive study to be carried out at the Consorci Corporació Sanitària Parc Taulí (CCSPT). The results of this study will provide information on the care received by patients admitted to COVID 19 affected by anxiety, fear or loneliness, the perceived impact of this care and will enable measures to be implemented to improve nursing care in the future. 450 patients, randomly selected from the Hospital de Sabadell database, will be included. In the sample, we will ensure that the proportion of women and men is in line with the distribution of the population to enable the incorporation of the gender perspective in the analyses. The quantitative variables will be described by means of their mean and standard deviation. Qualitative variables will be described in absolute and relative frequencies. In order to evaluate the suitability of the intervention to the needs of the patient, a table of concordance will be constructed between the actions proposed by the panel of experts and the actions carried out as referred by the patient. The kappa concordance index will be calculated and the degree of concordance will be classified according to the Landis and Koch scale. As regards the effectiveness of the intervention, the patients who were treated correctly and those who were not will be identified, and the percentage of positive impacts according to Csq-8 between the two groups will be compared by means of the Chi-square test.

Study Design

Study Type:
Observational
Anticipated Enrollment :
450 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Impact on Patients of Nurses' Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19
Actual Study Start Date :
Nov 27, 2020
Anticipated Primary Completion Date :
Apr 15, 2021
Anticipated Study Completion Date :
Apr 15, 2021

Arms and Interventions

Arm Intervention/Treatment
Patients COVID-19

Patients over the age of 18 who were admitted with a diagnosis of COVID-19 to any CCSPT unit between March 13, 2020 and April 30, 2020 and were discharged with a recovery result

Other: Nursing care to reduce anxiety, fear and loneliness
Decreased anxiety Presence Emotional support Improved security Increasing coping capacity Presence Emotional support Facilitating visits

Outcome Measures

Primary Outcome Measures

  1. The adequacy of nursing care to the needs of the patient [6 months after care]

    kappa concordance rate between care provided and care needed

Secondary Outcome Measures

  1. Intervention effectiveness [6 months after care]

    comparison of the percentage of positive impacts according to Csq-8 between the two groups using the Chi-square test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients over the age of 18 who were admitted with a diagnosis of COVID-19 to any CCSPT unit between March 13, 2020 and April 30, 2020 and were discharged with a recovery result
Exclusion Criteria:
  • Communication problems or inability to read and speak Spanish

Contacts and Locations

Locations

Site City State Country Postal Code
1 CorporacionPT Sabadell Barcelona Spain 08208

Sponsors and Collaborators

  • Corporacion Parc Tauli

Investigators

  • Principal Investigator: Montserrat Montaña, PhD, Corporación Parc Taulí

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Montserrat Montaña, Principal Investigator, Clinical Research, Corporacion Parc Tauli
ClinicalTrials.gov Identifier:
NCT04481477
Other Study ID Numbers:
  • 2020664
First Posted:
Jul 22, 2020
Last Update Posted:
Mar 25, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Montserrat Montaña, Principal Investigator, Clinical Research, Corporacion Parc Tauli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 25, 2021